Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
about
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequencesGene therapy for severe combined immunodeficiency: are we there yet?Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficienciesBacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseasesMolecular basis of engineered meganuclease targeting of the endogenous human RAG1 locusRole of non-homologous end joining in V(D)J recombinationTOX2 regulates human natural killer cell development by controlling T-BET expressionAutoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repairSCID dogs: similar transplant potential but distinct intra-uterine growth defects and premature replicative senescence compared with SCID mice.T-cell Receptor and K-deleting Recombination Excision Circles in Newborn Screening of T- and B-cell Defects: Review of the Literature and Future Challenges.Genetic resistance to rhabdovirus infection in teleost fish is paralleled to the derived cell resistance status.AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineagesA nonsense mutation in IKBKB causes combined immunodeficiency.Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiencySuccessful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID.Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningReticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.CD45-deficient severe combined immunodeficiency caused by uniparental disomy.Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning.A journey of hope: lessons learned from studies on rare diseases and orphan drugs.Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection.The effects of aging and maternal protein restriction during lactation on thymic involution and peripheral immunosenescence in adult miceAdoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.Human genetics of infectious diseases: between proof of principle and paradigm.Evidence of innate lymphoid cell redundancy in humans.How I treat ADA deficiency.Gene therapy: progress in childhood disease.The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment.Severe combined immunodeficiences: new and old scenarios.From murine to human nude/SCID: the thymus, T-cell development and the missing link.Modern management of primary T-cell immunodeficiencies.Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies.The immunological function of CD52 and its targeting in organ transplantation.Periodontal and other oral manifestations of immunodeficiency diseases.Human CD5+ Innate Lymphoid Cells Are Functionally Immature and Their Development from CD34+ Progenitor Cells Is Regulated by Id2.Primary immunodeficiencies suggest redundancy within the human immune system.
P2860
Q24670002-15CE4579-DE27-4744-9226-B60AF5C284B4Q24680426-C6A8FCF9-E76C-4328-92D9-6D7D8326DCB3Q26827084-57649715-39D0-411A-9578-373C389FB45CQ26863260-5E681E68-E38E-4791-BB2F-12AD11404D69Q27664531-1C02A72C-9D1A-462D-ABF5-DAFEF74374EEQ28266265-71460730-238C-4F6A-8589-ED20680D903FQ28854590-4AE29ECF-A36F-4636-9C5D-BCEA41DC30F1Q33403252-DC880A4F-5FD0-45CF-AD40-A2D097CB4451Q33432320-23DE3097-F8A1-4F33-8878-7B9CDBDCB67DQ33719388-A9BAD7F6-0B5D-4D0A-9243-2774C1142DD3Q34074060-5E871791-5F91-4F6F-89E8-22927B78BD72Q34238427-FB7889DE-D244-4DA5-A3B3-5E0FFC9C9E3EQ34489406-FCD3DA3B-ECD4-44B6-939E-C8DF35E39DE5Q34660085-9B401704-9D04-441D-A6E3-7BA0C59556B5Q34999354-2A72CBC3-E3CA-4D52-9260-EC4187DECE7FQ35603408-4AB2DCD2-185D-48F3-A384-99207C2D8F11Q35701287-2B3CC15E-FEAC-4194-9ED4-C07FE36A9829Q35728637-18A6CA47-0342-401E-857B-C8CE5C9DD4CBQ35894385-468F926E-6DEA-4B50-ACC9-78E0D20DE5EBQ36068963-1B175ACB-60B5-45D0-B601-F3CB3473CDA2Q36227853-BFB715C9-FED9-4643-BE39-909B3E8D2297Q36514274-6A62CA3A-7FFB-463B-97A6-131162C14D66Q36535366-2EC6A030-0B13-4E00-9D97-7B7D414F300FQ36916254-BC0ABF31-495F-4038-B074-27FA2E7E87FDQ37120772-235A9218-60A6-4E32-B447-86175446764DQ37194056-95D1FC56-97CD-4127-949A-E09CA4BE779AQ37199007-45CDC5F9-545D-4296-B9BC-9F4D97BDA4C4Q37328431-6F81AD81-958A-400D-A794-FF2DCF34BED4Q37357543-AED9F60E-5040-4975-89A0-30D325B67E2CQ37398309-11006FB5-9C10-4947-B78D-01E98DE794D0Q37948091-5F3E1D9D-4030-4117-8082-978F9AC03BCCQ37962986-CF0AA9C5-8745-405C-9C71-5F3C15F5A540Q37976472-8AEE7D45-27DF-41CE-A877-73875CECF3CCQ37999788-7DD00FFC-1B99-4F2A-9703-94C7CD1606D2Q38175191-F9986789-5133-4110-A44B-09068AAC7BB4Q38511550-5409D380-00D4-492B-BB00-08247FE964FEQ38747419-34827A5E-5FDA-4F6A-B817-47EB4FE9F127Q38954801-25E0B560-ED07-48F3-A34C-8A69D1141ADAQ40044886-B60EC870-DBFD-4AA3-8CA5-2A97E5652247Q40103750-25600A2C-83DD-4FE0-AA8C-5F20B719310B
P2860
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@ast
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@en
type
label
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@ast
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@en
prefLabel
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@ast
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@en
P2860
P50
P1476
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
@en
P2093
Isabelle André-Schmutz
Jean-Pierre de Villartay
P2860
P304
P356
10.1111/J.0105-2896.2005.00223.X
P50
P577
2005-02-01T00:00:00Z